Effectiveness of semaglutide versus liraglutide for treating post‐metabolic and bariatric surgery weight recurrence

Abstract

These results show that treatment regimens including semaglutide 1.0 mg weekly lead to superior weight loss compared with liraglutide 3.0 mg daily for treating post-MBS weight recurrence, regardless of procedure type or the magnitude of weight recurrence.